Plan B Pharma Loses, Children and Parents Win

Following today’s decision to keep restrictions on the availability of Plan B, Rita Diller, national director of American Life League’s STOPP project issued the following statement:

One study that Plan B manufacturer Teva Pharmaceuticals cited as justification for eliminating existing age restrictions showed that up to 28 percent of girls 12 to 17 were not able to safely use the drug after simply reading the directions on the packet. Another study looked at girls as young as 11 years of age.

Have we become so numb to the sexualization of our children that 11-year-old girls need unrestricted access to abortifacient drugs?

And how does such a policy not promote child sexual abuse rather than protect young girls from sexual predators and dangerous sexual activity in the first place?

Putting these drugs in stores like they are tissue or eye drops just makes it easier for predators to abuse children and then cover up the abuse.

Claims that “politics has trumped science” coming out of radical women’s groups today in the wake of the ruling are ridiculous.  HHS Secretary Kathleen Sebelius is a huge supporter of Planned Parenthood and its entire agenda, with her foot as firmly planted in sexual politics as anyone alive, and perhaps even she saw that making this drug accessible to young children is dangerous on multiple levels.

The decision to not remove age restrictions on Plan B was the right decision. In addition to the unintended consequences, not only do the risks associated with its use increase with frequent use, its efficacy in preventing pregnancy decreases.

In reality, the FDA should revisit the whole idea of treating this drug as “emergency contraception” when Plan B has the ability to abort an already created child who has not yet implanted.